JOHN MIZELLE: Open Payments
NPI 1174099279 · GUNTERSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,959 in 72 payments from 19 companies in 2025. Trend: 2023 $2,035 · 2024 $1,843 · 2025 $1,959
Food & beverage: $1,959
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $674 |
| ABBVIE INC. | 14 | $369 |
| PFIZER INC. | 6 | $183 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $138 |
| Novo Nordisk Inc | 3 | $116 |
| GlaxoSmithKline, LLC. | 5 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $71 |
| Ardelyx, Inc. | 3 | $61 |
| Exact Sciences Corporation | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
Products named: VRAYLAR, BREZTRI, AIRSUPRA, Kerendia, Ozempic, TRELEGY ELLIPTA, ZAVZPRET, NURTEC ODT.
Industry payments across AL — which companies pay providers there.
